Shari L. Taylor, MD

1996–1998 Fellow, Gastrointestinal and Liver Pathology, University of Washington Medical Center

1991–1996 Resident, Pathology, University of Tennessee, Baptist Memorial Hospital

1991 MD, University of Nebraska, Omaha

2008 Anatomic and Clinical Pathology

American Association for the Study of Liver Diseases

Rodger C. Haggit Gastrointestinal Pathology Society

United States and Canadian Academy of Pathology

American Gastroenterological Association

American Society of Clinical Pathologists

College of American Pathologists

Sangle NA, Taylor SL, Emond MJ, Depot M, et al. Overdiagnosis of high-grade dysplasia in Barrett’s esophagus: a multicenter, international study. Mod Pathol. 2015; 28:758–65.

Young EJ, Hasanjani Roushan MR, Shafae S, Genta RM, Taylor SL. Liver histology of acute brucellosis caused by Brucella melitensis. Hum Pathol. 2014; 45:2023–8.

Taylor SL, Haque S. Hepatobiliary pathology. Curr Opin Gastroenterol. 2011 May; 27(3):248–55.

McConn DJ, Lin YS, Mathisen TL, Blough DK, Xu Y, Hashizume T, Taylor SL, et al. Reduced duodenal cytochrome P450 3A protein expression and catalytic activity in patients with cirrhosis. Clin Pharmacol Ther. 2009; 85:387–93.

Bronner MP, Overholt BF, Taylor SL, Haggitt RC, et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett’s esophagus with high grade dysplasia. Gastroenterology. 2009; 136:56–64.

Allende D, Taylor SL, Bronner MP. Colonic perforation as a complication of collagenous colitis in a series of 12 patients. Am J Gastroenterol. 2008;103:2598–604.

Murray KF, Finn LS, Taylor SL, Seidel KD, Larson AM. Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection. J Pediatr Gastroenterol Nutr. 2005; 41:634–8.

Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot M; International Photodynamic Group for High-Grade Dysplasia in Barrett’s esophagus. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett’s esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005; 62:488–98.

Eng SC, Taylor SL, Reyes V, Raaka S, Berger J, Kowdley KV. Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis. Liver Int. 2005; 25:513–7.

Castellino S, Lensing S, Riely C, Rai SN, Davila R, Hayden RT, Fleckenstein J, Levstik M, Taylor S, Dean PJ, Kippenbrock S, Pope J, Carr J, Strickland DK, Hudson MM. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children’s Research Hospital hepatitis C seropositive cohort. Blood. 2004; 103:2460–6.

Duhart BT Jr, Honaker MR, Shokouh-Amiri MH, Riely CA, Vera SR, Taylor SL, Al-jedai AH, Gaber AO. Retrospective evaluation of the risk of hepatitis B virus reactivation after transplantation. Transpl Infect Dis. 2003; 5:126–31.

Kitagawa Y, Unger TA, Taylor S, Kozarek RA, Traverso LW. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg. 2003; 7:12–8; discussion 18–9.

Larson AM, Taylor SL, Bauermeister D, Rosoff Jr L, Kowdley KV. Pilot study of relationship between histologic progression and hepatic iron concentration in chronic hepatitis C. J Clin Gastroenterol. 2003; 37:406–11.

Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, HaggittR, Reed MS, Afonia IA, Rabinovitch PR, Stevens AC, Feng Z, Bronner MP: The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol. 2000; 157:737–45.

Cotler SJ, Taylor SL, Gretch DR, Bronner MP, Rizk R, Perkins JD, Carithers RL. Hyperbilirubinemia and cholestatic liver injury in hepatitis C- infected liver transplant recipients. American Journal of Gastroenterology. 2000; 95:653–759.

Chang M, Marquardt AP, Wood BL, Williams O, Cotler SJ, Taylor SL, Carithers RL, Gretch DR. In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease. Journal of Virology. 2000; 74:944–55.

Taylor SL, Rubin CE. Gastroduodenal pathology. Current Opinion in Gastroenterology. 1998; 14:433–6.

Vaezy S, Martin R, Schmieidl U, Caps M, Taylor S, Beach K, Carter S, Kaczkowski P, Keilman G, Helton S, Chandler W, Mourad P, Rice M, Roy, Crum L. Liver hemostasis using high intensity focused ultrasound. Ultrasound in Medicine and Biology. 1997; 23(9):1413–20.

Taylor SL, Dean PJ, Riely CA. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol. 1994; 18(1):91–9.